Explore Changping: Where Ming Dynasty Heritage Meets Modern Adventure
CHANGPING, China, June 18, 2025 /PRNewswire/ -- On June 14, the Ming Dynasty Culture Forum 2025 opened at the Ming Culture International Exchange Center in Changping District, Beijing. The Forum consists of an opening ceremony, four sub-forums and a...
APTO Releases High-Accuracy Japanese Reasoning Data for LLM Fine-Tuning, Free of Charge
TOKYO, June 18, 2025 /PRNewswire/ -- APTO is pleased to announce the release of a free dataset for fine-tuning reasoning models, such as OpenAI's GPT-01 and Deepseek's Deepseek R1. This dataset can help to improve reasoning ability in Japanese and...
TGE Successfully Advances Multiple Movie Releases This Year, Including "She's Got No Name" and "My First of May," Coming Out in June and August Respectively
PARIS and NEW YORK and SINGAPORE, June 18, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD" or the "Group"), alongside The Generation Essentials Group (NYSE: TGE), a subsidiary of the Group under AMTD Digital (NYSE: HKD), jointly announced that TGE is...
AI-Powered CDSS Enhances Patient Safety with Real-World Data
SAN FRANCISCO, June 18, 2025 /PRNewswire/ -- The growing demand for personalized medicine has accelerated the adoption of Real-World Data (RWD) in healthcare. The Tungs' Taichung MetroHarbor Hospital in Taiwan, in collaboration with AESOP...
Mine Vision Systems Expands Global Support Network with New Australian Partnership
Mine Vision Systems (MVS) today announced a strategic partnership with Hi! Engineers to enter the Australian market, a preeminent global mining hub. This collaboration will establish local expert service and support, significantly accelerating MVS's...
RemeGen's Telitacicept (RC18) Received Orphan Drug Designation from EMA for Myasthenia Gravis
YANTAI, China, June 17, 2025 /PRNewswire/ -- On June 16, 2025, RemeGen Co., Ltd. ("RemeGen", stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand name: 泰爱®) has received Orphan Drug Designation (ODD) from European Medicines...
Hexagon launches AEON, a humanoid built for industry
Hexagon leverages industry-leading expertise in measurement technologies, AI and autonomous systems to introduce an advanced humanoid robot to accelerate next-generation autonomy AEON combines best-in-class locomotion, sensor fusion, and AI-based...
Polus holds €425 million initial close for third CLO equity fund
One of Europe's largest raises of its kind highlights Polus' leadership in the CLO and leveraged credit markets. LONDON, June 17, 2025 /PRNewswire/ -- Polus Capital Management ("Polus"), an investment management firm specialising in alternative...